Arm CEO: chip shortage delays AI-driven cancer research breakthroughs

Arm's CEO states that AI-powered cancer modeling is currently constrained by chip shortages, delaying potential cures. The claim is an executive opinion on industry capacity, not a confirmed scientific or market event. It signals supply-chain bottlenecks persist in high-performance computing, affecting biotech R&D timelines.